Delivery Order SPE2DE22D0008-SPE2D625F7FL8
- Not listed
- This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the supply of specialized in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, valued at $6,750.00, was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to support defense medical operations. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV), likely a Blanket Purchase Agreement...
- This federal contract award is for the delivery of ALBACYTE antibody screening (3-cell) products to the Defense Logistics Agency (DLA). The contract, valued at $1,281.00, was awarded to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other biomedical products to various federal agencies, including the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS). The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies, including the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS). The contract, valued at $1,304.00, is for the delivery of an ALBAHANCE LISS...
- This federal contract award is for the delivery of ALBACYTE antibody screening tests (3-cell) to the Defense Logistics Agency (DLA). The $1,281.00 firm-fixed-price contract was awarded to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The award is not associated with a set-aside program and serves as a delivery order under the company's existing federal contract vehicles, including a...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking products. The contract, worth $1,740.00, is a delivery order under contract SPE2DE22D0008|SPE2D625F15SJ, awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain. The contract is for the supply of ALBACYTE Antibody ID Panels, which are specialized 16-cell panels used for antibody identification in blood banking operations. This contract does...
- This federal contract award, valued at $7,590.00, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other specialized biomedical products to various federal agencies. The contract is for the delivery of ALBACYTE Antibody ID Panels, which are essential blood banking supplies used to support the DLA's medical operations. Alba Bioscience holds multiple...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking reagents. The contract was awarded by the Defense Logistics Agency (DLA) and has a ceiling value of $17,441.00. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the supply of ALBACLONE Anti-P1 medical products, which are likely critical blood banking supplies supporting diagnostic testing, blood typing, and...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking supplies. The contract, valued at $4,582.00, is a Delivery Order contract with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the provision of ALBACYTE Antibody ID Panels, which are specialized blood banking products used for diagnostic testing, blood typing, and transfusion...
- This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The $1,118.00 Firm Fixed Price Delivery Order (SPE2DE22D0008|SPE2D625F38A1) is for the product "ALBACLONE ANTI-A" and has an ultimate completion date of December...
- This federal contract award, valued at $1,239.00, was made to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, awarded by the Defense Logistics Agency's Medical Supply Chain division, is for the delivery of ALBACYTE antibody screening cells, a critical product used in blood banking operations across various government agencies, including...
- SPE2DE22D0008Indefinite Delivery Contract
- SPE2DE22D0008-SPE2D625F7FL8Delivery Order
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization based in Chicago, Illinois, that specializes in the production and distribution of in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials for federal healthcare systems. The contract, worth $1,118.00, is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 22, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency. Alba Bioscience has been awarded this contract to provide a wide range of essential reagents, antibodies, and testing kits used in medical laboratories across various government agencies, including the Department of Veterans Affairs (VA) and the National Institutes of Health (NIH). The contract is not set-aside and is part of two significant federal contract Indefinite Delivery Vehicles (IDVs), or Blanket Purchase Agreements (BPAs), that Alba Bioscience holds with the VA, valued at $199,671.75 and $109,420.35, respectively.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/17/25 |